medroxyprogesterone acetate has been researched along with Cachexia in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 9 (56.25) | 18.2507 |
| 2000's | 6 (37.50) | 29.6817 |
| 2010's | 1 (6.25) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Macciò, A; Madeddu, C; Mantovani, G; Panzone, F; Tanca, FM | 1 |
| Chen, SZ; Zhang, YL | 1 |
| Antonietti, C; Gilli, G; Lelli, G; Montanari, M; Scapoli, D | 1 |
| Cerchietti, LC; Diament, MJ; Klein, SM; Navigante, A; Peluffo, GD; Ranuncolo, SM; Stillitani, I | 1 |
| Contu, P; Deiana, L; Dessì, M; Floris, C; Gramignano, G; Macciò, A; Madeddu, C; Mantovani, G; Massa, E; Panzone, F; Sanna, E; Serpe, R; Tanca, FM | 1 |
| Baccino, FM; Costelli, P; Tessitore, L | 1 |
| Allbright, A; Downer, S; Joel, S; Plant, H; Slevin, M; Stubbs, L; Talbot, D | 1 |
| Fournier, F; Livrozet, JM; Rambeaud, B; Saint-Marc, T; Touraine, JL | 1 |
| Del Giacco, S; Dessì, D; Esu, S; Lai, P; Macciò, A; Mantovani, G; Massa, E; Melis, G; Santona, MC | 1 |
| Del Giacco, GS; Dessì, D; Esu, S; Lai, P; Macciò, A; Mantovani, G; Massa, E; Melis, GB; Santona, MC | 1 |
| Hoefnagels, JM; Schols, AM; Simons, JP; ten Velde, GP; Westerterp, KR; Wouters, EF | 1 |
| Ghiani, M; Lai, P; Macciò, A; Mantovani, G; Massa, E; Santona, MC | 2 |
| Kurebayashi, J; Otsuki, T; Sonoo, H; Yamamoto, S | 1 |
| Ogawa, M; Yamashita, JI | 1 |
| Mantovani, G | 1 |
5 review(s) available for medroxyprogesterone acetate and Cachexia
| Article | Year |
|---|---|
Medroxyprogesterone acetate in the management of cancer cachexia.
Topics: Animals; Cachexia; Humans; Medroxyprogesterone Acetate; Neoplasms | 2009 |
Treatment of the cancer anorexia-cachexia syndrome: a critical reappraisal.
Topics: Anorexia; Cachexia; Clinical Trials as Topic; Drug Therapy, Combination; Female; Humans; Male; Medroxyprogesterone Acetate; Megestrol Acetate; Metoclopramide; Neoplasms; Prognosis; Risk Assessment; Severity of Illness Index; Survival Analysis; Terminally Ill; Treatment Outcome; Wasting Syndrome | 2003 |
Cytokine activity in cancer-related anorexia/cachexia: role of megestrol acetate and medroxyprogesterone acetate.
Topics: Anorexia; Appetite Stimulants; Cachexia; Cytokines; Humans; Interleukin-1; Interleukin-6; Medroxyprogesterone Acetate; Megestrol Acetate; Neoplasms; Progesterone Congeners; Tumor Necrosis Factor-alpha; Wasting Syndrome | 1998 |
Cytokine involvement in cancer anorexia/cachexia: role of megestrol acetate and medroxyprogesterone acetate on cytokine downregulation and improvement of clinical symptoms.
Topics: Anorexia; Antineoplastic Agents; Appetite Stimulants; Cachexia; Clinical Trials as Topic; Cytokines; Humans; Medroxyprogesterone Acetate; Megestrol Acetate; Neoplasm Proteins; Neoplasms; Progesterone Congeners; Serotonin | 1998 |
Medroxyprogesterone acetate and cancer cachexia: interleukin-6 involvement.
Topics: Cachexia; Female; Humans; Interleukin-6; Medroxyprogesterone Acetate; Neoplasms | 2000 |
3 trial(s) available for medroxyprogesterone acetate and Cachexia
| Article | Year |
|---|---|
Randomized phase III clinical trial of five different arms of treatment for patients with cancer cachexia: interim results.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Antioxidants; Appetite Stimulants; Ascorbic Acid; Basal Metabolism; Cachexia; Carnitine; Dietary Supplements; Exercise; Fatigue; Female; Humans; Interleukin-6; Male; Medroxyprogesterone Acetate; Megestrol Acetate; Middle Aged; Muscle Proteins; Neoplasms; Nutritional Support; Oxidative Stress; Treatment Outcome; Tumor Necrosis Factor-alpha; Vitamin A; Vitamin E | 2008 |
A double blind placebo controlled trial of medroxyprogesterone acetate (MPA) in cancer cachexia.
Topics: Appetite; Cachexia; Double-Blind Method; Humans; Medroxyprogesterone Acetate; Middle Aged; Neoplasms; Prealbumin; Retinol-Binding Proteins | 1993 |
Effects of medroxyprogesterone acetate on food intake, body composition, and resting energy expenditure in patients with advanced, nonhormone-sensitive cancer: a randomized, placebo-controlled trial.
Topics: Aged; Appetite; Body Composition; Cachexia; Double-Blind Method; Eating; Energy Metabolism; Female; Humans; Male; Medroxyprogesterone Acetate; Neoplasms; Progesterone Congeners; Weight Loss | 1998 |
8 other study(ies) available for medroxyprogesterone acetate and Cachexia
| Article | Year |
|---|---|
Treatment of cancer cachexia in mice by combination of dsRNA-dependent protein kinase inhibitor and medroxyprogesterone acetate.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Blood Glucose; Body Weight; Cachexia; Cytokines; Disease Models, Animal; eIF-2 Kinase; Humans; Male; Medroxyprogesterone Acetate; Mice; Mice, Inbred BALB C; Muscle, Skeletal; Neoplasms; Protein Kinase Inhibitors; Tumor Burden | 2012 |
Inhibition of tumor progression and paraneoplastic syndrome development in a murine lung adenocarcinoma by medroxyprogesterone acetate and indomethacin.
Topics: Adenocarcinoma; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Appetite Stimulants; Cachexia; Enzyme-Linked Immunosorbent Assay; Female; Hypercalcemia; Indomethacin; Interleukin-1; Interleukin-6; Lung Neoplasms; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Medroxyprogesterone Acetate; Mice; Mice, Inbred BALB C; Paraneoplastic Syndromes | 2006 |
Pharmacological interference with tissue hypercatabolism in tumour-bearing rats.
Topics: Adrenalectomy; Animals; Aspirin; Blood Glucose; Body Weight; Cachexia; Cathepsin D; Cholesterol; Endopeptidases; Hormones; Insulin; Leupeptins; Male; Medroxyprogesterone Acetate; Muscle Proteins; Neoplasm Transplantation; Neoplasms, Experimental; Rats; Rats, Wistar; Triglycerides | 1994 |
[Value of acetate medroxyprogesterone in the treatment of cachexia in AIDS].
Topics: Acquired Immunodeficiency Syndrome; Adult; Cachexia; Humans; Medroxyprogesterone Acetate | 1993 |
Medroxyprogesterone acetate reduces the production of cytokines and serotonin involved in anorexia/cachexia and emesis by peripheral blood mononuclear cells of cancer patients.
Topics: Anorexia; Antigens, CD; Cachexia; Cells, Cultured; Cytokines; Enzyme-Linked Immunosorbent Assay; Female; Humans; Interleukins; Lymphocyte Activation; Lymphocytes; Medroxyprogesterone Acetate; Neoplasms; Receptors, Interleukin-2; Serotonin; Tumor Necrosis Factor-alpha; Vomiting | 1997 |
Medroxyprogesterone acetate reduces the in vitro production of cytokines and serotonin involved in anorexia/cachexia and emesis by peripheral blood mononuclear cells of cancer patients.
Topics: Aged; Anorexia; Antineoplastic Agents, Hormonal; Cachexia; Cell Division; Cells, Cultured; Cytokines; Female; Humans; Interleukin-1; Interleukin-2; Interleukin-6; Leukocytes, Mononuclear; Male; Medroxyprogesterone Acetate; Middle Aged; Neoplasms; Receptors, Interleukin-2; Serotonin; Tumor Necrosis Factor-alpha; Vomiting | 1997 |
Medroxyprogesterone acetate inhibits interleukin 6 secretion from KPL-4 human breast cancer cells both in vitro and in vivo: a possible mechanism of the anticachectic effect.
Topics: Animals; Antineoplastic Agents, Hormonal; Body Weight; Breast Neoplasms; Cachexia; Female; Humans; Injections, Intramuscular; Interleukin-6; Medroxyprogesterone Acetate; Mice; Mice, Nude; Neoplasm Transplantation; Tumor Cells, Cultured | 1999 |
Cachexia and anorexia.
Topics: Anorexia; Cachexia; Cytokines; Humans; Medroxyprogesterone Acetate; Megestrol Acetate; Neoplasms; Progesterone Congeners | 2000 |